FURTHER OBSERVATIONS ON THE EFFECTS OF CLOMIPHENE CITRATE IN ANOVULATORY FEMALES.
D015068:17-Ketosteroids; D000230:Adenocarcinoma; D001284:Atrophy; D006063:Chorionic Gonadotropin; D002996:Clomiphene; D003933:Diagnosis; D004358:Drug Therapy; D004715:Endometriosis; D004717:Endometrium; D005260:Female; D005640:Follicle Stimulating Hormone; D005831:Genital Diseases, Female; D006062:Gonadotropins; D006801:Humans; D006965:Hyperplasia; D007246:Infertility; D007247:Infertility, Female; D010060:Ovulation; D010336:Pathology; D011085:Polycystic Ovary Syndrome; D013267:Stilbenes; D014116:Toxicology; D014556:Urine; D014594:Uterine Neoplasms
D015068:17-Ketosteroids; D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D013267:Stilbenes; D002996:Clomiphene; D005640:Follicle Stimulating Hormone
17-KETOSTEROIDS; ADENOCARCINOMA; ATROPHY; CLOMIPHENE; DIAGNOSIS; DRUG THERAPY; ENDOMETRIOSIS; ENDOMETRIUM; FSH; GONADOTROPINS, CHORIONIC; GYNECOLOGIC DISEASES; HYPERPLASIA; OVULATION; PATHOLOGY; STEIN-LEVENTHAL SYNDROME; STERILITY, FEMALE; STILBENES; TOXICOLOGIC REPORT; URINE; UTERINE NEOPLASMS